226例老年人群抗精神病药物药品不良反应的回顾分析
Retrospective Analysis of 226 Cases of Adverse Reactions to Antipsychotic Drugs in the Elderly Population
DOI: 10.12677/hjmce.2025.132015, PDF,   
作者: 曾永保*：四川省宜宾市翠屏区白花镇中心卫生院药剂科，四川 宜宾；蒲从福, 徐 霞：宜宾市第四人民医院药学部，四川 宜宾
关键词: 药品不良反应；抗精神病药物；老年；Adverse Drug Reactions； Antipsychotic Drugs； Elderly Population
摘要: 目的：分析老年人群抗精神病药物药品不良反应(adverse drug reactions, ADR)的发生特点，为老年人群用药安全提供参考。方法：从ADR监测系统提取2019年至2023年抗精神病药物所有ADR，筛选年龄 ≥ 60岁的ADR报告进行回顾分析。结果：共226例ADR纳入本次分析，ADR涉及神经、消化、心血管等多个系统/器官，主要表现为锥体外系反应、肝功能异常、心律失常等。结论：抗精神病药物ADR涉及多个系统/器官，给临床治疗带来不利影响。小剂量开始给药、注意给药疗程，注重ADR监测有利于提高老年人群用药安全。
Abstract: Objective: To provid reference for safe medication in the elderly population by analyze the characteristics and patterns of adverse drug reactions (ADR) associated with antipsychotic drugs. Methods: Extract all ADRs reported from 2019 to 2023 from the ADR monitoring system, screen for adverse drug reaction reports of drugs aged ≥ 60 years old with suspected use of antipsychotic drugs for retrospective analysis. Results: A total of 226 cases of ADR were included in this analysis, ADR involves multiple systems/organs such as the nervous system, digestive system, cardiovascular system, and endocrine system, mainly manifested as extra pyramidal reactions, abnormal liver function, arrhythmia, and abnormal glucose and lipid metabolism. Conclusion: Antipsychotic drug ADR involves multiple systems/organs, with complex and diverse clinical manifestations that may affect treatment outcomes. Starting small doses of medication, paying attention to the course of treatment, and monitoring ADR are beneficial for improving medication safety in the elderly population.
文章引用：曾永保, 蒲从福, 徐霞. 226例老年人群抗精神病药物药品不良反应的回顾分析[J]. 药物化学, 2025, 13(2): 145-149. https://doi.org/10.12677/hjmce.2025.132015

参考文献

[1] 国家药品监督管理局药品评价中心, 国家药品不良反应监测中心. 国家药品不良反应监测年度报告(2022年) [EB/OL].
https://www.cdr-adr.org.cn/, 2023-03-02.
[2] Chawla, S. and Kumar, S. (2017) Adverse Drug Reactions and Their Impact on Quality of Life in Patients on Antipsychotic Therapy at a Tertiary Care Center in Delhi. Indian Journal of Psychological Medicine, 39, 293-298. [Google Scholar] [CrossRef] [PubMed]
[3] 国家药品不良反应监测中心. 药品不良反应报告和监测工作手册[EB/OL].
http://111.202.232.186/CDR/help/index/index.html, 2012-11-01, 2019-06-29.
[4] 国家药品不良反应监测中心. 药品不良反应术语使用指南[S]. 中国医药科技, 2003.
[5] Oh, S., Byeon, S. and Chung, S.J. (2022) Characteristics of Adverse Reactions among Antipsychotic Drugs Using the Korean Adverse Event Reporting System Database from 2010 to 2019. Journal of Psychopharmacology, 36, 1041-1050. [Google Scholar] [CrossRef] [PubMed]
[6] 曹莉莎, 王继生, 张芳, 等. 631例抗精神病药物药品不良反应分析[J]. 中国药物警戒, 2022, 19(3): 322-324.
[7] Chippa, V. and Roy, K. (2023) Geriatric Cognitive Decline and Polypharmacy. StatPearls Publishing.
https://www.ncbi.nlm.nih.gov/books/NBK574575/
[8] Pollak, T.A., Drndarski, S., Stone, J.M., David, A.S., McGuire, P. and Abbott, N.J. (2018) The Blood-Brain Barrier in Psychosis. The Lancet Psychiatry, 5, 79-92. [Google Scholar] [CrossRef] [PubMed]
[9] Montagne, A., Nation, D.A., Sagare, A.P., Barisano, G., Sweeney, M.D., Chakhoyan, A., et al. (2020) APOE4 Leads to Blood-Brain Barrier Dysfunction Predicting Cognitive Decline. Nature, 581, 71-76. [Google Scholar] [CrossRef] [PubMed]
[10] 石娟娟, 张家瑞, 袁卓, 等. 利培酮诱导大鼠便秘作用研究[J]. 中国新药杂志, 2017, 26(4): 460-464.
[11] Lee, S.H., Kim, H.R., Han, R.X., Oqani, R.K. and Jin, D.I. (2011) Cardiovascular Risk Assessment of Atypical Antipsychotic Drugs in a Zebrafish Model. Journal of Applied Toxicology, 33, 466-470. [Google Scholar] [CrossRef] [PubMed]